Heart Test Laboratories (HSCS) to Release Earnings on Thursday

Heart Test Laboratories (NASDAQ:HSCS) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of ($2.53) per share for the quarter.

Heart Test Laboratories (NASDAQ:HSCS) last released its quarterly earnings data on Monday, December 16th. The company reported ($2.27) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.30) by $0.03. During the same period in the previous year, the business posted ($15.92) EPS. On average, analysts expect Heart Test Laboratories to post $-10 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

Heart Test Laboratories Stock Performance

NASDAQ:HSCS opened at $2.92 on Wednesday. The firm has a market cap of $2.86 million, a PE ratio of -0.37 and a beta of 2.76. Heart Test Laboratories has a fifty-two week low of $2.36 and a fifty-two week high of $13.50. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.52 and a current ratio of 1.72. The business has a 50 day moving average price of $3.49 and a 200-day moving average price of $3.44.

Analyst Upgrades and Downgrades

Separately, Maxim Group reissued a “buy” rating and set a $12.00 price objective on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.